Bionoia Where life meets thought ⌕
Back to Journal
Journal › Microbiome ecology
Discovery

Paeoniflorin Ameliorates Alcohol-Induced Depression via Modulating the Gut-Brain Axis and Inhibiting the NF-κB/NLRP3 Inflammasome Pathway in Mice

Speculation
Read original paper
Editor's note
A plant-derived compound restores mood-related behavior in alcohol-exposed mice by reshaping their gut microbiota and reducing brain inflammation, suggesting the microbiome may mediate alcohol's depressive effects. This mechanistic mouse work sits at the frontier of gut-brain psychiatry but requires human validation before clinical relevance emerges. Microbiome researchers, addiction medicine specialists, and neuropharmacologists investigating microbial interventions for mood disorders should track this pathway.

Source: europepmc · Origin: CN · Yu J, Zhang R, Quan Y, Sun D, Huang C, Xu J, Li X, Liu L. · Phytotherapy research : PTR · 2026-05-26

URL: https://pubmed.ncbi.nlm.nih.gov/42186379/

AI rationale (4/5, tier: preliminary): Mouse model with 16S+metabolomics on alcohol dysbiosis and gut-brain axis; mechanism-driven but animal-only limits priority.

Paeoniflorin (PF), the primary bioactive component of Paeonia plants, exhibits neuroprotective and anti-inflammatory activities. However, its potential role in alcohol-induced depression (AID) through the microbiota-metabolite-brain axis remains unclear. This study aimed to investigate the antidepressant effect of PF and its underlying gut-brain communication mechanisms. A mouse model of chronic alcohol exposure was established and treated with PF. Behavioral tests (SPT, FST, TST, OFT) and histopathological examinations were conducted. Network pharmacology and molecular docking were used to predict targets, followed by experimental validation of microglial activation and the NF-κB/NLRP3 pathway. Multi-omics approaches including 16S rRNA sequencing and untargeted metabolomics were applied to analyze gut microbiota and fecal metabolites. PF significantly alleviated depressive-like behaviors, hippocampal damage, and oxidative stress, while restoring monoamine neurotransmitter levels. It suppressed microglial activation and the NF-κB/NLRP3 inflammasome cascade. Furthermore, PF reshaped gut microbiota composition (reducing Rikenellaceae and Prevotellaceae) and modulated metabolite profiles and upregulated the neuroprotective metabolite niacin, along with other identified metabolites. These findings demonstrate that PF alleviates Alcohol-Induced Depression (AID) by remodeling the microbiota-metabolite-brain axis and inhibiting neuroinflammation. The study highlights PF's therapeutic potential for alcohol-related mood disorders and underscores the gut-brain axis as a critical target for antidepressant therapy.

Related articles in this corpus

Parallel
1,25-Dihydroxyvitamin D3 mitigates high glucose-induced oxidative stress, inflammation, and extracellular matrix accumulation in glomerular mesangial cells via the ROS/TXNIP/NLRP3 pathway
Both articles investigate anti-inflammatory therapeutic interventions targeting the NLRP3 inflammasome pathway in different disease contexts (diabetic nephropathy and alcohol-induced depression), sharing a common mechanistic focus but applied to distinct organ systems and etiologies.
Parallel
Gut Microbiota Dysbiosis Remodels the Multi-Tissue Transcriptional Landscape of the Host
Both articles investigate gut microbiota's systemic effects on host physiology, with A focusing on a specific therapeutic intervention (paeoniflorin) for alcohol-induced depression via the gut-brain axis, while B examines the broader transcriptional mechanisms by which microbiota dysbiosis remodels multi-tissue gene expression.
Parallel
Multi-omics Analysis Reveals the Protection of a Quadruple Probiotic Mixture in Experimental Autoimmune Hepatitis
Both studies investigate gut microbiota-mediated therapeutic interventions for chronic inflammatory conditions through the gut-brain/gut-liver axis, but target different disease models (alcohol-induced depression vs. autoimmune hepatitis) with different treatment modalities (single compound vs. probiotic mixture).
Parallel
Sichuan dark tea with a medicine-food-homology formula synergistically alleviates alcohol-associated gut microbiota disturbance, liver steatosis and death in mice
Both articles investigate natural compound interventions (paeoniflorin and Sichuan dark tea) against alcohol-induced pathology through gut microbiota modulation, but focus on different disease outcomes (depression vs. liver disease) and employ distinct mechanistic pathways.
Parallel
Irisin-integrin αV/β5 coupling of α-synuclein phagocytosis and clearance
Both articles examine neuroprotective mechanisms against neurodegenerative/neuropsychiatric conditions through natural compounds via distinct pathways (irisin-integrin signaling for α-synuclein clearance in PD versus paeoniflorin-microbiota modulation in alcohol-induced depression), with no direct mechanistic overlap.
Published 2026-05-28 · Last kit-update 2026-05-28